Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis
Author(s) -
Gaelle Makafe,
Yuanyuan Cao,
Yaoju Tan,
Mugweru Julius,
Xiaogang Li,
Changwei Wang,
Moses Njire,
Xingshan Cai,
Tianzhou Liu,
Bangxing Wang,
Wei Pang,
Shouyong Tan,
Buchang Zhang,
Wing Wai Yew,
Gyanu Lamichhane,
Jintao Guo,
Tianyu Zhang
Publication year - 2016
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00152-16
Subject(s) - mycobacterium tuberculosis , microbiology and biotechnology , recombinant dna , mycobacterium , biology , gene , ribosomal rna , mutation , ribosomal protein , tuberculosis , genetics , chemistry , bacteria , ribosome , rna , medicine , pathology
We expressed the wild-typerplC and mutatedrplC (Cys154Arg) genes, respectively, inMycobacterium tuberculosis H37Ra and H37Rv in an attempt to delineate the role ofrplC (Cys154Arg) regarding oxazolidinone resistance. An increase of the MICs of linezolid (LZD) and sutezolid (PNU-100480, PNU) against the recombinant mycobacteria with overexpressedrplC mutation (Cys154Arg) was found, suggesting therplC gene is a determinant of bacillary susceptibilities to LZD and PNU.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom